{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:20:43Z","timestamp":1793996443770,"version":"4.8.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.critrevonc.2020.102962","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:28:38Z","timestamp":1587166118000},"page":"102962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-5906","authenticated-orcid":false,"given":"Ross D.","family":"Dolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4260-5334","authenticated-orcid":false,"given":"Donald C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2020.102962_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091304","article-title":"The Relationship between Imaging-Based Body Composition Analysis and the Systemic Inflammatory Response in Patients with Cancer: A Systematic Review","volume":"11","author":"Abbass","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/hepr.12597","article-title":"Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation","volume":"46","author":"Abe","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjc.6602922","article-title":"Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer","volume":"94","author":"Al Murri","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/0284186X.2014.948061","article-title":"Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway","volume":"54","author":"Anshushaug","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0030","doi-asserted-by":"crossref","first-page":"e1702","DOI":"10.1097\/MD.0000000000001702","article-title":"Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis","volume":"94","author":"Arigami","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000444494","article-title":"A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer","volume":"90","author":"Arigami","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0040","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1245\/s10434-014-3533-9","article-title":"Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer","volume":"21","author":"Aurello","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(04)01569-4","article-title":"The economics of cancer care in the UK","volume":"5","author":"Bosanquet","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0060","article-title":"The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer","author":"Chan","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.21147\/j.issn.1000-9604.2017.03.02","article-title":"Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer","volume":"29","author":"Chang","year":"2017","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0070","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/hed.24853","article-title":"Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy","volume":"39","author":"Chang","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12904-015-0011-5","article-title":"The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care","volume":"14","author":"Chou","year":"2015","journal-title":"BMC. Palliat. Care"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0080","first-page":"1869","article-title":"Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer","volume":"20","author":"Chua","year":"2012","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjsurg.2007.12.052","article-title":"Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer","volume":"197","author":"Crozier","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0090","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1245\/s10434-011-1658-7","article-title":"Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer","volume":"18","author":"Crumley","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bjc.6602998","article-title":"Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer","volume":"94","author":"Crumley","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0100","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1111\/j.1440-1746.2007.05105.x","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer","volume":"23","author":"Crumley","year":"2008","journal-title":"J. Gastroenterol. Hepatol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jpainsymman.2015.09.010","article-title":"Validation of the Modified Glasgow Prognostic Score in Advanced Cancer Patients Receiving Palliative Care","volume":"51","author":"De Paula","year":"2016","journal-title":"J. Pain Symptom. Manage"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0110","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.critrevonc.2018.09.016","article-title":"The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review","volume":"132","author":"Dolan","year":"2018","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0120","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis","volume":"116","author":"Dolan","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41416-018-0095-9","article-title":"The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores","volume":"119","author":"Dolan","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jcsm.12022","article-title":"Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2\u2019 patients","volume":"6","author":"Dreanic","year":"2015","journal-title":"J. Cachexia. Sarcopenia. Muscle"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0140","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1245\/s10434-011-1676-5","article-title":"A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection","volume":"18","author":"Dutta","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0145","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00268-011-1130-7","article-title":"Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer","volume":"35","author":"Dutta","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.amjsurg.2011.10.015","article-title":"Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer","volume":"204","author":"Dutta","year":"2012","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/bjc.2011.610","article-title":"The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma","volume":"106","author":"Dutta","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1207\/s15327914nc4802_6","article-title":"Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer","volume":"48","author":"Elahi","year":"2004","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0165","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00432-015-2113-0","article-title":"Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer","volume":"142","author":"Fan","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bjoms.2014.10.007","article-title":"Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma","volume":"53","author":"Farhan-Alanie","year":"2015","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/1319-3767.126319","article-title":"Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma","volume":"20","author":"Feng","year":"2014","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0180","doi-asserted-by":"crossref","first-page":"e1861","DOI":"10.1097\/MD.0000000000001861","article-title":"Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience","volume":"94","author":"Ferro","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0185","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","article-title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer","volume":"89","author":"Forrest","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejca.2013.11.003","article-title":"Comparison of visual and automated assessment of tumour inflammatory infiltrates in patients with colorectal cancer","volume":"50","author":"Forrest","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0195","doi-asserted-by":"crossref","first-page":"e2784","DOI":"10.1097\/MD.0000000000002784","article-title":"A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article","volume":"95","author":"Fu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10147-017-1221-z","article-title":"Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy","volume":"23","author":"Fukuda","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0205","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.lungcan.2012.04.008","article-title":"The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer","volume":"77","author":"Gioulbasanis","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0210","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000094562","article-title":"Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer","volume":"6","author":"Glen","year":"2006","journal-title":"Pancreatology"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0215","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/bjc.2013.330","article-title":"Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer","volume":"109","author":"Guthrie","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejogrb.2009.12.027","article-title":"The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer","volume":"149","author":"Hefler-Frischmuth","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0230","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ejso.2015.07.008","article-title":"Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer","volume":"41","author":"Hirahara","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0235","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00535-013-0855-5","article-title":"Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer","volume":"49","author":"Hirashima","year":"2014","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jgo.2017.09.009","article-title":"Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial","volume":"9","author":"Honecker","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0245","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10147-012-0451-3","article-title":"Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma","volume":"18","author":"Horino","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0250","doi-asserted-by":"crossref","first-page":"e3504","DOI":"10.1097\/MD.0000000000003504","article-title":"A Prognostic Model Using Inflammation- and Nutrition-Based Scores in Patients With Metastatic Gastric Adenocarcinoma Treated With Chemotherapy","volume":"95","author":"Hsieh","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0255","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s12032-014-0883-x","article-title":"The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy","volume":"31","author":"Huang","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0260","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1200\/JCO.2015.61.4578","article-title":"Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed","volume":"33","author":"Hurwitz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0265","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jjco\/hys124","article-title":"Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer","volume":"42","author":"Hwang","year":"2012","journal-title":"Jpn. J. Clin. Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0270","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1471-2407-11-489","article-title":"Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer","volume":"11","author":"Hwang","year":"2011","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0275","doi-asserted-by":"crossref","first-page":"113248","DOI":"10.18632\/oncotarget.22641","article-title":"The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma","volume":"8","author":"Inamoto","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0280","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000343822","article-title":"Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer","volume":"84","author":"Inoue","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0285","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jso.21294","article-title":"Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer","volume":"100","author":"Ishizuka","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0290","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jso.21857","article-title":"Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma","volume":"103","author":"Ishizuka","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjsurg.2010.09.030","article-title":"Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients","volume":"203","author":"Ishizuka","year":"2012","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0300","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/SLA.0b013e3181454171","article-title":"Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer","volume":"246","author":"Ishizuka","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0305","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1245\/s10434-012-2384-5","article-title":"Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen","volume":"19","author":"Ishizuka","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0310","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.2013.350","article-title":"Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer","volume":"109","author":"Ishizuka","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amjsurg.2012.04.012","article-title":"Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer","volume":"205","author":"Ishizuka","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0320","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1245\/s10434-015-4948-7","article-title":"Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer","volume":"23","author":"Ishizuka","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0325","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/SLA.0b013e3181b16e24","article-title":"Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer","volume":"250","author":"Ishizuka","year":"2009","journal-title":"Ann. Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0330","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1245\/s10434-011-1560-3","article-title":"A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma","volume":"18","author":"Jamieson","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0335","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1245\/s10434-012-2370-y","article-title":"The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma","volume":"19","author":"Jamieson","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0340","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000342376","article-title":"Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer","volume":"83","author":"Jeong","year":"2012","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0345","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12885-015-1403-x","article-title":"The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer","volume":"15","author":"Jiang","year":"2015","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0350","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/bjc.2012.262","article-title":"Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer","volume":"107","author":"Jiang","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0355","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000360068","article-title":"Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma","volume":"133","author":"Jung","year":"2015","journal-title":"Acta Haematol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0360","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00280-014-2665-8","article-title":"Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival","volume":"75","author":"Kasuga","year":"2015","journal-title":"Cancer Chemother. Pharmacol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0365","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/icvts\/ivv223","article-title":"Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery","volume":"21","author":"Kawashima","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0370","doi-asserted-by":"crossref","first-page":"179.e19","DOI":"10.1016\/j.urolonc.2018.11.005","article-title":"Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer","volume":"37","author":"Kimura","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0375","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000280021","article-title":"Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival","volume":"27","author":"Kobayashi","year":"2010","journal-title":"Dig Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0380","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.surg.2008.08.015","article-title":"Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma","volume":"144","author":"Kobayashi","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0385","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000276910","article-title":"Inflammation-based prognostic score and number of lymph node metastases are independent prognostic factors in esophageal squamous cell carcinoma","volume":"27","author":"Kobayashi","year":"2010","journal-title":"Dig Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0390","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s11605-012-2036-x","article-title":"Significance of the inflammation-based Glasgow prognostic score for short- and long-term outcomes after curative resection of gastric cancer","volume":"16","author":"Kubota","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0395","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1245\/s10434-012-2348-9","article-title":"The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma","volume":"19","author":"La Torre","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0400","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0405","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.2011.556","article-title":"Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems","volume":"106","author":"Lamb","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0410","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.bjc.6604027","article-title":"Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer","volume":"97","author":"Leitch","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0415","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.bjc.6604027","article-title":"Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer","volume":"97","author":"Leitch","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0420","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/JTO.0b013e318244ffe1","article-title":"Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer","volume":"7","author":"Leung","year":"2012","journal-title":"J. Thorac. Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0425","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cam4.947","article-title":"An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study","volume":"6","author":"Li","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0430","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clgc.2013.04.020","article-title":"Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy","volume":"11","author":"Linton","year":"2013","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0435","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12885-017-3220-x","article-title":"The prognostic value of the preoperative c-reactive protein\/albumin ratio in ovarian cancer","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0440","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(08)60241-X","article-title":"Tumour immunity: effector response to tumour and role of the microenvironment","volume":"371","author":"Mantovani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0445","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/imj.12453","article-title":"Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer","volume":"44","author":"Martin","year":"2014","journal-title":"Intern. Med. J"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0450","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1245\/s10434-014-3857-5","article-title":"Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score","volume":"22","author":"Matsuda","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0455","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"Mcallister","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0460","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00384-006-0259-6","article-title":"Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer","volume":"22","author":"Mcmillan","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0465","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.surg.2016.01.018","article-title":"Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment","volume":"159","author":"Melling","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0470","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MPA.0000000000000465","article-title":"C-Reactive Protein Level Is an Indicator of the Aggressiveness of Advanced Pancreatic Cancer","volume":"45","author":"Mitsunaga","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0475","first-page":"3149","article-title":"Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study","volume":"23","author":"Miura","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0480","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1093\/ejcts\/ezu514","article-title":"Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer","volume":"47","author":"Miyazaki","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0485","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12032-014-0287-y","article-title":"Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status","volume":"31","author":"Moriwaki","year":"2014","journal-title":"Med. Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0490","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/bjs.7294","article-title":"Comparison of positive lymph node ratio with an inflammation-based prognostic score in colorectal cancer","volume":"98","author":"Moug","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0495","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1245\/s10434-013-3342-6","article-title":"The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases","volume":"21","author":"Nakagawa","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0500","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00595-013-0628-z","article-title":"New prognostic score for the survival of patients with esophageal squamous cell carcinoma","volume":"44","author":"Nakamura","year":"2014","journal-title":"Surg Today"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0505","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000446373","article-title":"Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer","volume":"90","author":"Namikawa","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0510","doi-asserted-by":"crossref","first-page":"e1486","DOI":"10.1097\/MD.0000000000001486","article-title":"Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma","volume":"94","author":"Ni","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0515","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjsurg.2010.01.030","article-title":"Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma","volume":"201","author":"Nozoe","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0520","doi-asserted-by":"crossref","first-page":"512","DOI":"10.9738\/INTSURG-D-13-00118.1","article-title":"Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma","volume":"99","author":"Nozoe","year":"2014","journal-title":"Int Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0525","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00268-015-2982-z","article-title":"Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma","volume":"39","author":"Okamura","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0530","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s10147-017-1154-6","article-title":"Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303)","volume":"22","author":"Okuno","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0535","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00534-012-0550-6","article-title":"Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma","volume":"20","author":"Oshiro","year":"2013","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0540","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/dote.12316","article-title":"Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II\/III esophageal cancer","volume":"29","author":"Otowa","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0545","first-page":"3097","article-title":"A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma","volume":"38","author":"Owari","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0550","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bjc.2016.17","article-title":"Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment","volume":"114","author":"Park","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0555","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/SLA.0000000000001122","article-title":"Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host","volume":"263","author":"Park","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0560","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpainsymman.2011.08.013","article-title":"Prognostication in advanced cancer: a study examining an inflammation-based score","volume":"44","author":"Partridge","year":"2012","journal-title":"J. Pain Symptom. Manage"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177620","article-title":"The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer","volume":"12","author":"Paulsen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0570","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/bjc.2014.145","article-title":"Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer","volume":"110","author":"Pinato","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0575","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1463-1318.2012.03048.x","article-title":"The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer","volume":"14","author":"Powell","year":"2012","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0580","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6605855","article-title":"The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study","volume":"103","author":"Proctor","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0585","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000334971","article-title":"Prospective study of the role of inflammation in renal cancer","volume":"88","author":"Qayyum","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0590","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1464-410X.2008.07466.x","article-title":"The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancer","volume":"102","author":"Ramsey","year":"2008","journal-title":"BJU. Int"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0595","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cncr.22400","article-title":"Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer","volume":"109","author":"Ramsey","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0600","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1207\/s15327914nc5501_10","article-title":"Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival","volume":"55","author":"Read","year":"2006","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0605","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/sj.bjc.6605919","article-title":"The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer","volume":"103","author":"Richards","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0610","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/bjs.7755","article-title":"Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer","volume":"99","author":"Richards","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0615","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00280-013-2111-3","article-title":"Phase II randomized trial of carboplatin and gemcitabine with or without dexamethasone pre-treatment in patients with Stage IV non-small cell lung cancer","volume":"71","author":"Rinehart","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0620","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2017.10.019","article-title":"Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)","volume":"148","author":"Roncolato","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0625","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00384-010-1120-5","article-title":"Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors","volume":"26","author":"Roxburgh","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0630","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1245\/s10434-010-1410-8","article-title":"Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer","volume":"18","author":"Roxburgh","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0635","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/SLA.0b013e3181a3e738","article-title":"Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer","volume":"249","author":"Roxburgh","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0640","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1463-1318.2009.01961.x","article-title":"Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer","volume":"12","author":"Roxburgh","year":"2010","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0645","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1080\/01635581.2014.956261","article-title":"Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer","volume":"66","author":"Sachlova","year":"2014","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0650","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejogrb.2017.01.024","article-title":"Glasgow prognostic score is a prognosis predictor for patients with endometrial cancer","volume":"210","author":"Saijo","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0655","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00404-018-4993-0","article-title":"Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score","volume":"299","author":"Seebacher","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0660","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00268-014-2844-0","article-title":"Glasgow prognostic score predicts outcome after surgical resection of gallbladder cancer","volume":"39","author":"Shiba","year":"2015","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0665","first-page":"2715","article-title":"Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater","volume":"33","author":"Shiba","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0670","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12957-015-0609-3","article-title":"The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer","volume":"13","author":"Shibutani","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0675","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.lungcan.2015.03.020","article-title":"Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factors","volume":"88","author":"Simmons","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0680","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1245\/s10434-013-2968-8","article-title":"Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer","volume":"20","author":"Son","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0685","first-page":"300","article-title":"Prognostic value of preoperative systemic inflammation markers in localized upper tract urothelial cell carcinoma: a large, multicenter cohort analysis","volume":"70","author":"Son","year":"2018","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0690","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.3748\/wjg.v21.i43.12410","article-title":"Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients","volume":"21","author":"Song","year":"2015","journal-title":"World J. Gastroenterol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0695","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.2013.332","article-title":"Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer","volume":"109","author":"Stotz","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0700","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000346002","article-title":"Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer","volume":"29","author":"Sugimoto","year":"2012","journal-title":"Dig Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0705","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.3748\/wjg.v20.i26.8583","article-title":"Prognostic significance of preoperative fibrinogen in patients with colon cancer","volume":"20","author":"Sun","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0710","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000362601","article-title":"The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer","volume":"87","author":"Takeno","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0715","first-page":"385","article-title":"The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study","volume":"23","author":"Tan","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0720","doi-asserted-by":"crossref","first-page":"75013","DOI":"10.18632\/oncotarget.12601","article-title":"Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer","volume":"7","author":"Thomsen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0725","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1186\/s12885-016-2696-0","article-title":"The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study","volume":"16","author":"Toyokawa","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0730","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-017-5948-6","article-title":"Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy","volume":"24","author":"Tsujino","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0735","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1245\/s10434-010-1383-7","article-title":"Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer","volume":"18","author":"Vashist","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0740","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jso.24225","article-title":"Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?","volume":"113","author":"Walsh","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0745","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s13277-011-0285-z","article-title":"Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer","volume":"33","author":"Wang","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0750","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjsurg.2014.12.031","article-title":"Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer","volume":"210","author":"Watt","year":"2015","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0755","series-title":"World Health Organization Cancer Fact Sheet","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0760","series-title":"Cancer Statistics","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0765","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/s10434-013-3292-z","article-title":"Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma","volume":"21","author":"Wu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0770","first-page":"5273","article-title":"Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy","volume":"8","author":"Xiao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0775","article-title":"A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein\/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0780","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7150\/jca.9569","article-title":"The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy","volume":"5","author":"Zhang","year":"2014","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0785","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.3748\/wjg.v21.i18.5582","article-title":"Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization","volume":"21","author":"Zhou","year":"2015","journal-title":"World J. Gastroenterol"},{"key":"10.1016\/j.critrevonc.2020.102962_bib0790","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13277-014-2623-4","article-title":"A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer","volume":"36","author":"Zhou","year":"2015","journal-title":"Tumour. Biol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820301001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820301001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:33:43Z","timestamp":1760902423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842820301001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":158,"alternative-id":["S1040842820301001"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102962","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102962"}}